FIGURE

Fig. 4

ID

ZDB-FIG-200907-5

Publication

Zhou et al., 2019 - Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Timo AIII inhibits endothelial cell proliferation in HUVECs. a HUVECs were treated with various concentrations of Timo AIII (0.5, 1, 2, 4, and 8 µM) for 24 h, and cell viability was tested by the MTT assay. b HUVEC cells were cotreated with VEGF (50 ng/mL) and various concentrations of Timo AIII (0.5, 1, 2, and 4 µM) or SU5416 (1 µM), which served as a positive control, for 24 h, and cell viability was determined by the MTT assay. c Cell impedance, which was expressed as the cell index and measured by the xCELLigence Real-time cell analysis (RTCA) system, was used to evaluate the proliferation in HUVECs. HUVECs were treated with VEGF (50 ng/mL), Timo AIII (2 µM), or VEGF (50 ng/mL) + Timo AIII (2 µM) for 48 h, and cell impedance was detected at 1-h intervals. Data are presented as the percentage of the control group. The results are presented as the means ± S.E.M. ^##P < 0.01 and ^###P < 0.001 versus the control group. *P < 0.05, ***P < 0.001 versus the VEGF-treated group

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharmacol. Sin.